Lucid Tala vs Otofonix Groove

The Lucid Tala is a premium-priced OTC hearing aid at $1,300, earning an A grade with a SoundScore of 4.6/5 in our lab testing. Ranking #4 among 65 OTC hearing aids tested, it places in the top 5% of its category and has received HearAdvisor's Expert's Choice Award in both 2023 and 2024. Speech performance is a clear strength. Speech in Quiet scores an excellent 4.6/5, measuring 1.85 points above the category average. Speech in Noise reaches a solid 3.0/5, which is 1.56 points above the OTC average of 1.48—a meaningful advantage for conversations in challenging environments. Music streaming also performs well at 3.0/5, exceeding the category average by 1.08 points. The primary weakness is feedback handling, which scores a low 1.7/5 in our tuned testing—2.84 points below the category average of 4.54. This suggests users may experience more whistling or feedback artifacts than typical OTC devices. Own-voice comfort is mixed at 2.6/5, sitting just above the category average but not standing out in absolute terms. The Lucid Tala is best suited for users who prioritize speech clarity and are willing to pay premium OTC pricing for strong intelligibility performance. Those highly sensitive to feedback may want to consider alternatives. At this price point, comparable options include the Audicus Omni 2, though budget-conscious shoppers might explore lower-priced devices like the Elehear Beyond or Yeasound RIC700, which also deliver strong sound performance in our testing.

The Otofonix Groove is a behind-the-ear prescription hearing aid priced at $795, earning a C grade with a SoundScore of 2.7/5 in our lab testing. This rechargeable BTE device ranks 36th out of 36 tested prescription hearing aids, placing it in the bottom tier of its category. In our testing, the Groove demonstrated one clear strength: excellent feedback handling at 5.0/5, scoring 0.29 points above the category average. The device remained stable during our standardized challenge motions with no audible feedback issues. However, speech performance was significantly limited, with both speech in quiet and speech in noise scoring 1.0/5—falling 2.32 and 0.96 points below their respective category averages. Music streaming quality scored 0.0/5, which is 2.64 points below the prescription category average. Own-voice comfort was also low at 0.4/5 in the tuned configuration, 2.35 points below average, suggesting notable occlusion-related concerns. The normalized Initial Score of 2.7/5 and Tuned Score of 2.6/5 indicate that professional fitting adjustments did not improve overall performance. Given its positioning at the bottom of the prescription hearing aid category and the availability of lower-priced alternatives that scored higher in our testing, the Otofonix Groove may be difficult to recommend for most users seeking balanced sound quality across listening situations.